Guggenheim analyst Yatin Suneja downgrades Relmada Therapeutics (NASDAQ:RLMD) from Buy to Neutral.
Analyst Ratings for ShockWave Medical
Within the last quarter, ShockWave Medical (NASDAQ:SWAV) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…